The thick peptidoglycan layers of Gram-positive bacteria are connected to polyanionic glycopolymers called wall teichoic acids (WTA). Pathogens such as Staphylococcus aureus, Listeria monocytogenes, or Enterococcus faecalis produce WTA with diverse, usually strain-specific structure. Extensive studies on S. aureus WTA mutants revealed important functions of WTA in cell division, growth, morphogenesis, resistance to antimicrobials, and interaction with host or phages. While most of the S. aureus WTA-biosynthetic genes have been identified it remained unclear for long how and why S. aureus glycosylates WTA with ␣-or ␤-linked N-acetylglucosamine (GlcNAc). Only recently the discovery of two WTA glycosyltransferases, TarM and TarS, yielded fundamental insights into the roles of S. aureus WTA glycosylation. Mutants lacking WTA GlcNAc are resistant towards most of the S. aureus phages and, surprisingly, TarS-mediated WTA ␤-O-GlcNAc modification is essential for ␤-lactam resistance in methicillin-resistant S. aureus. Notably, S. aureus WTA GlcNAc residues are major antigens and activate the complement system contributing to opsonophagocytosis. WTA glycosylation with a variety of sugars and corresponding glycosyltransferases were also identified in other Gram-positive bacteria, which paves the way for detailed investigations on the diverse roles of WTA modification with sugar residues.
Introduction
The Gram-positive bacterium Staphylococcus aureus is one of the most successful opportunistic pathogens causing severe infections worldwide. The natural niche of S. aureus are the nares of healthy humans and S. aureus nasal carriage was shown to be a major risk factor for acquiring invasive infections (von Eiff et al., 2001) .
Successful colonization of human nares and infection of tissues requires efficient mechanisms to counteract human defense systems and efficient attachment to human cells. One of the most important S. aureus nasal colonization factors is the cell wallbound wall teichoic acid (WTA) (Weidenmaier et al., 2004) , a cell surface polymer produced by most Gram-positive bacteria including major human pathogens such as Streptococcus pneumoniae, Listeria monocytogenes or Enterococcus faecalis (Denapaite et al., 2012; Fiedler, 1988; Geiss-Liebisch et al., 2012) . Interestingly, WTA structures are highly diverse among Gram-positive bacteria and are often strain or species-specific (Neuhaus and Baddiley, 2003; Weidenmaier and Peschel, 2008) . In most S. aureus clones including highly virulent strains such as USA300 and MW2 the WTA polymer consist of 11-40 ribitol-phosphate (RboP) repeating units substituted with d-alanine (d-ala) and N-acetylglucosamine (GlcNAc). The WTA polymer is covalently linked to the 6-OH group of N-acetylmuramic acid residues in peptidoglycan via a disaccharide consisting of GlcNAc-1-P and N-actelymannosamine followed by two glycerol-phosphate (GroP) units (Weidenmaier and Peschel, 2008) (Fig. 1A) . In addition to WTA S. aureus and most other Gram-positive bacteria produce membrane-bound lipoteichoic acids (LTA) whose backbone is composed of GroP repeating units (Reichmann and Grundling, 2011) .
Major functional roles of S. aureus WTA were elucidated during the last couple of years using defined mutants with targeted deletion of WTA biosynthesis genes such as the dltABCD operon responsible for the d-alanylation of WTA (Peschel et al., 1999) . dala residues on WTA (and LTA) contribute to resistance to cationic antimicrobial peptides such as defensins or cathelicidins (Collins et al., 2002; Peschel et al., 1999) and to glycopeptide antibiotics such as vancomycin or teicoplanin (Peschel et al., 2000) . Moreover, deletion of tagO encoding the first enzyme of the WTA biosynthesis pathway revealed that WTA is dispensable for S. aureus viability under laboratory conditions (Weidenmaier et al., 2004) but affects several critical cellular processes including autolysis After anchor synthesis, priming, and polymerization TarM and TarS glycosylate the WTA polymer, which is subsequently exported across the cytoplasmic membrane (TagGH), alanylated (DltABCD), and covalently linked to the peptdioglycan via LcpA (sa1195), B (sa0908) and C (sa2103). (B) WTA biosynthesis gene clusters of S. aureus. WTA glycosyltransferases tarM and tarS, a putative glycosyltransferase tagX and the WTA d-alanylation gene cluster are indicated (coloured). The location of a transposase (SAB0902c) within the tarM gene cluster present in the bovine S. aureus isolate RF122 (*) and genes with unknown functions are indicated (?). (C) Known functions of WTA ␣-and ␤-glycosylation in S. aureus. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) (Vergara-Irigaray et al., 2008 ), cell division (Brown et al., 2012 Campbell et al., 2011) , localization of penicillin binding protein 4 (PBP4) (Atilano et al., 2010) , and survival at high temperatures (Vergara-Irigaray et al., 2008) . Remarkably, S. aureus WTA contributes to biofilm formation (Vergara-Irigaray et al., 2008) , adhesion to epithelial (Weidenmaier et al., 2004) and endothelial cells, and is important for severe invasive infections such as endocarditis (Weidenmaier et al., 2005) . S. aureus WTA elicits robust antibody responses in humans and activates the human complement system via both the classical and the mannose-binding lectin pathway leading to opsonophagocytosis (Jung et al., 2012; Kurokawa et al., 2013; Park et al., 2010) . How variation of WTA structure may affect the interaction of S. aureus with the innate and adaptive immune systems remains to be investigated. During the last 60 years S. aureus increasingly acquired resistance genes to counteract extensive antibiotic treatment (Chambers and Deleo, 2009) . Of note, WTAs are exposed at the S. aureus cell surface and they are required for PBP2a-mediated ␤-lactam antibiotic resistance Farha et al., 2013; Maki et al., 1994) . Moreover, S. aureus mutants lacking WTA are susceptible to antimicrobial fatty acids from human skin (Kohler et al., 2009 ) and WTA contributes to S. aureus lysozyme resistance (Bera et al., 2007) suggesting a general protective role of WTA against antimicrobials. Because of its importance in vivo and in resistance to ␤-lactam antibiotics S. aureus WTA represents a very attractive target for the development of new antibiotics. Recently several promising novel compounds have been developed that inhibit TagO or the WTA transporter TagGH thereby rendering methicillin-resistant S. aureus (MRSA) susceptible to ␤-lactams Farha et al., 2013; Suzuki et al., 2011; Wang et al., 2013) . Thus, WTA inhibitors could become useful for blocking S. aureus adhesion to host cells or for sensitizing MRSA to ␤-lactams.
Interaction with the human host during colonization or infection or the role of WTA in resistance towards antimicrobials are probably important reasons why S. aureus is synthesizing such a polymer. From an evolutionary point of view WTA seems to have a crucial function because WTA serve as adsorption receptor for many staphylococcal phages (Chatterjee, 1969; Park et al., 1974) that are largely responsible for horizontal gene transfer in Staphylococcus.
Although most of the S. aureus enzymes required for WTA biosynthesis have been elucidated and many functions have been attributed to WTA in the past years, it remained a mystery for decades how does S. aureus glycosylate WTA. Of note, early studies revealed strain-specific anomeric configurations (␣-and ␤) of the WTA GlcNAc substitutions (Endl et al., 1984) suggesting that S. aureus may encode two different WTA glycosyltransferases. (tagGH), and d-alanylation (dltABCD) of S. aureus WTA were identified and studied in genetic and/or in vitro reconstitution approaches (Swoboda et al., 2010; Xia et al., 2010a) . Recently the ligation of WTA from lipid-linked WTA precursors to peptidoglycan was proposed to be accomplished by a new family of enzymes named LCP proteins (Chan et al., 2013; Dengler et al., 2012; Kawai et al., 2011) ( Fig. 1A and B). However, it remained unknown until recently, which genes encode the WTA glycosyltransferases in S. aureus (Fig. 1B) . S. aureus NCTC8325-4 encodes ca. 20 putative glycosyltransferases and interestingly, two putative glycosyltransferases are co-localized within well studied WTA biosynthesis gene clusters namely tarS and tagX (Brown et al., 2012; Swoboda et al., 2010; Xia et al., 2010a) (Fig. 1B) . In contrast, the WTA glycosyltransferase tarM (Xia et al., 2010b) does not co-localize with WTA gene clusters but is adjacent to genes encoding putative ABC transporters and proteins of unknown function (Fig. 1B) . Remarkably TarM does not exists in every S. aureus genome and seem to be strain specific (see below).
The two unrelated enzymes TarM and TarS glycosylate WTA of S. aureus
Evidence for WTA glycosylation by ␤-GlcNAc in S. aureus dates back to the 1960s and 1970s. WTA ␤-GlcNAc transferase activity was demonstrated in strain Copenhagen (Nathenson and Strominger, 1963 ) while a phage-resistant mutant 52B2 was found to lack any detectable WTA GlcNAc transferase activity (Shaw et al., 1970) . By screening a transposon mutant library derived from S. aureus strain RN4220, a mutant that was resistant to serogroup B phages was isolated and named K6. Sequencing analysis revealed that the transposon had disrupted a gene (SACOL1042), which encodes a putative glycosyltransferase. The gene product was named TarM. Based on the facts that mutant K6 that bears a transposon insertion in tarM lacked GlcNAc on WTAs and tarM complemented K6 mutant synthesizes ␣-O-GlcNAc on WTA, it was concluded that TarM is a WTA ␣-O-GlcNAc transferase (Xia et al., 2010b) . Surprisingly, unlike transposon mutant K6, a targeted tarM deletion mutant (S. aureus RN4220 tarM) was still phage-susceptible and nuclear magnetic resonance (NMR) elucidation revealed the presence of ␤-O-GlcNAc substituted WTA in this strain further suggesting S. aureus encodes a second WTA GlcNAc transferase, potentially tagX or tarS (Brown et al., 2012) . However, combined deletion of tarM and tagX did not alter phage susceptibility (Xia et al., unpublished data) and no in vitro WTA glycosyltransferase activity was found for TagX (Brown et al., 2012) . When the other putative ␤-glycosyltransferase gene tarS of mutant K6 was sequenced it was found to be truncated because of a point mutation. Moreover, TarS glycosylated RboP WTA polymers in vitro and deletion of both tarM and tarS resulted in complete absence of GlcNAc strongly suggesting tarS encodes the second S. aureus WTA glycosyltransferase (Brown et al., 2012) .
Thus, TarM and TarS represent the RboP WTA ␣-and ␤-OGlcNAc transferases, respectively, of S. aureus (Fig. 1A and B) .
Functional roles of WTA glycosylation in S. aureus
While the discovery of TarM and TarS clarified the molecular basis of WTA glycosylation several questions remained unanswered: (i) Why is S. aureus glycosylating its WTA, (ii) are there different functions for ␣-or ␤-O-GlcNAc residues linked to WTA, and (iii) how is WTA glycosylation regulated? Several early studies already suggested that WTA GlcNAc may serve as an adsorption receptor for serogroup B phages such as Ф52A (Chatterjee, 1969; Park et al., 1974) . However, S. aureus mutants lacking either ␣-or ␤-O-GlcNAc remained susceptible to most of the S. aureus phages while only the complete loss of WTA glycosylation resulted in phage resistance (Brown et al., 2012; Xia et al., 2010b Xia et al., , 2011 Xia and Wolz, 2013) (Table 1 and Fig. 1C ). Thus, serogroup B phages require WTA glycosylation for efficient adsorption and infection but do not distinguish between different anomeric configurations of the GlcNAc residues on WTA. Similar observations were made for horizontal transfer of S. aureus pathogenicity islands (SaPIs) by SaPI particles formed by helper phage proteins indicating that SaPI particles adopt the receptor specificities of helper phages and do not distinguish between different WTA GlcNAc configurations . Remarkably, similar WTA structures enable horizontal gene transfer among Gram-positive pathogenic bacteria, even across long phylogenetic distances (Table 1 and Fig. 1C) .
MRSA mutants lacking WTA were found to be highly susceptible to ␤-lactam antibiotics, such as methicillin Farha et al., 2013) . In contrast to MRSA mutants lacking either the d-alanine or ␣-O-GlcNAc substitutions on WTA, which were still resistant to most ␤-lactam antibiotics the lack of ␤-O-GlcNAc residues rendered MRSA susceptible to ␤-lactams (Brown et al., 2012) (Table 1 and Fig. 1C ). The reasons for the essential role of TarS in ␤-lactam resistance remain elusive. The WTA ␤-O-GlcNAc may serve as a scaffold for the cell wall synthesis complex or cell wall-associated proteins that directly or indirectly modulate PBP2a activity (Brown et al., 2012) . Along this line there is evidence that PBP2a and PBP4 interact with WTA (Atilano et al., 2010; Qamar and Golemi-Kotra, 2012) . However, it is also possible that WTA glycosylation affects the physicochemical properties of the peptidoglycan matrix by influencing the cell wall milieu (Sutcliffe, 2012) .
Mutants lacking ␤-O-GlcNAc were also more susceptible to lysostaphin, which cleaves the pentaglycine crossbridges of S. aureus peptidoglycan, than the parental strains (Brown et al., 2012) suggesting that WTA ␤-O-GlcNAc interferes with binding of lysostaphin to peptidoglycan (Fig. 1C) . In contrast, several other critical processes that depend on WTA such as autolysis, biofilm formation, and cell division were not affected in mutants lacking WTA glycosylation (Brown et al., 2012) (Fig. 1C) . Interestingly, there are first indications that S. aureus can modulate the relative amounts of ␣-and ␤-glycosylation depending on environmental conditions. tarS but not tarM expression levels were strongly upregulated by oxacillin treatment, which underscores the critical role of TarS in ␤-lactam resistance (Brown et al., 2012) .
Human sera contain high levels of antibodies directed against the ␤-GlcNAc residues of S. aureus WTA indicating that these modifications can be dominant antigens in staphylococcal infections (Kurokawa et al., 2013) . Moreover, human MBL was found to bind to glycosylated WTA and activated the lectin pathway of complement (Kurokawa et al., 2013) (Table 1 and Fig. 1C ).
It remains unclear, which S. aureus regulation system controls the WTA glycosylation pattern and if there are further conditions by which tarM or tarS expression is affected. Thus, WTA glycosylation plays crucial roles in the susceptibility of S. aureus to phages, ␤-lactam antibiotics, lysostaphin and interaction with the human immune system.
tarM is absent in several S. aureus clonal complexes
While tarS was found in nearly all so far sequenced S. aureus genomes tarM is absent in several strains (Table 2 ). In particular tarM seems to be an ancient feature of S. aureus because the very early branching S. aureus clonal complex (CC) 75, sequence type (ST) 1850 strain MSHR1132 bears both, tarS and tarM in its genome (Holt et al., 2011) (Table 2) (Eugster et al., 2011) , phage resistance (Tran et al., 1999) L. monocytogenes serotype 4b
RboP (Glc, Gal) Phage resistance (Cheng et al., 2008) ; attenuated virulence in gastrointestinal listeriosis (mice) (Faith et al., 2009 
AATGal-Glc-RboP-GalNAc-GalNAc (GalNAc e & P-Cho)
No mutants described; phosphocholine moieties contribute to virulence (Gehre et al., 2009; Kharat and Tomasz, 2006) a WTA repeating units (bold) and WTA glycosylation ( ) are indicated. b Ribitol-phosphate (RboP), glycerol-phosphate (GroP), N-acetylglucosamine (GlcNAc), N-acetylgalactosamine (GalNAc), glucose (Glc), Rhamnose (Rha), Galactose (Gal), 2-acetamido-4-amino-2,4,6-trideoxygalactose (AATGal) and phosphorylcholine (P-Cho) are indicated. (all CC5) or certain ST398 strains ( Table 2 ). As indicated in Table 2 there was no correlation between the presence or absence of tarM and the MRSA status but the absence of tarM seems to be a conserved feature of certain STs or even of several closely related STs.
In addition, there was no correlation of tarM with host specificity, e.g. human or bovine origin (e.g. USA300 or RF122, respectively; both bear tarM) ( Table 2 ). It can be assumed that the loss of tarM happened repeatedly but only rarely during S. aureus evolution. 
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Currently it is mysterious where tarM came from during S. aureus evolution and if tarM is mobile. tarM may have been acquired via horizontal gene transfer since tarM is flanked by a transposase possibly contributing to mobility e.g. in the bovine S. aureus isolate RF122 (Table 2 and Fig. 1B ). In addition, it remains unclear if there is any advantage of bearing or losing tarM and if ␣-glycosylated WTA is beneficial for certain S. aureus lineages during colonization or infection or for susceptibility to certain phages.
Role of WTA glycosylation in other Gram-positive bacteria
Most of the Gram-positive bacteria have WTAs of highly variable composition and structure at their cell surfaces. Even among staphylococcal species WTA structures are quite diverse (Endl et al., 1984) . While S. aureus WTA is composed of RboP units most of the coagulase-negative staphylococci (CoNS) produce GroP WTAs or WTA polymers with complex composition containing e.g. hexoses in the WTA backbones (Endl et al., 1984) . Most WTAs of CoNS are glycosylated with sugars other than GlcNAc that is found in most S. aureus (Endl et al., 1984) (Table 1) . Thus, bearing tarM and tarS and especially ␤-O-GlcNAc WTA glycosylation seems to be a specific feature of S. aureus raising the question why CoNS use different glycosylation patterns and which genes are involved. Of note early studies revealed that certain S. aureus produce WTA structures other than the common RboP polymer, e.g. S. aureus strains 187 and 406, which were found to produce GroP WTA substituted with ␣-O-linked N-acetylgalactosamine (GalNAc) (Endl et al., 1984) . Recently such a GroP type WTA structure was verified in S. aureus strain PS187 by using NMR spectroscopy . It seems that those S. aureus strains with GroP WTA may be more related to CoNS in terms of cell envelope structure than to classical S. aureus strains.
WTAs produced by other Gram-positive bacteria are in some instances similar to S. aureus WTA but most were shown to be highly diverse (Neuhaus and Baddiley, 2003; Weidenmaier and Peschel, 2008) . Extensive investigations elucidated WTA structure, function, and biosynthesis in Bacillus subtilis. B. subtilis strain 168 produces GroP WTA substituted with ␣-linked glucose (Glc) while strain W23 produced RboP WTA modified with ␤-Glc (Brown et al., 2012; Neuhaus and Baddiley, 2003; Swoboda et al., 2010) (Table 1) . Decades ago it was shown that glucosylated WTA were required for phage adsorption in B. subtilis 168 (Young, 1967) (Table 1 ) and the TagE protein (also called GtaA and RodD) of B. subtilis 168 was proposed as the WTA glucosyltransferase based on the indirect genetic evidence (Honeyman and Stewart, 1989; Mauel et al., 1989) . Recently, TagE was characterized and demonstrated to be a GroP WTA ␣-glucosyl transferase (Allison et al., 2011) . Thus, WTA glycosylation in B. subtilis and S. aureus share similar functions such as phage adsorption and infection. In addition TarQ was recently found to act as a ␤-O-glucosyl transferase in B. subtilis strain W23 producing RboP WTA substituted with ␤-Glc (Brown et al., 2012) .
Human pathogens from the genus Listeria including certain serotypes of L. monocytogenes or L. grayi produce WTA with RboP repeating units identical to those found in S. aureus (Fiedler, 1988) . Often their WTA glycosylation pattern is also shared with S. aureus but additional sugars such as rhamnose or Glc were described (Fiedler, 1988) (Table 1) . Studies on WTA glycosylation in Listeria revealed functions related to those of S. aureus. WTA glycosyl residues of L. monocytogenes serve as adsorption receptors for different Listeria phages (Cheng et al., 2008; Tran et al., 1999) and can contribute to virulence, e.g. to gastrointestinal listeriosis in mice (Faith et al., 2009) (Table 1 ). In agreement with these findings the cell wall binding domain (CBD) of Listeria phage endolysin PlyP35 was found to recognize the GlcNAc residues on WTA (Eugster et al., 2011) (Table 1) . However, this property does not seem to be a common feature of all Listeria phage endolysins (Eugster and Loessner, 2012) . WTA was also shown to restrict the access of certain phage endolysin CBDs to the peptidoglycan of L. monocytogenes (Eugster and Loessner, 2012) . In contrast Enterococcus spp. WTAs have a very complex structure, which is distinct from that of S. aureus or Listeria. Of note, E. faecalis or E. faecium produce different WTAs with hexose-containing repeating units (GalNAc-RboP glycosylated with ␣-linked rhamnose or Glc-GalNAc-RboP glycosylated with ␣-linked Glc, both WTAs found in E. faecalis V583 whereas non-substituted GalNAc-GroP, type WTA was found in E. faecium U0317) (Bychowska et al., 2011; Geiss-Liebisch et al., 2012) (Table 1) . Although some functions of Enterococcus WTAs including evasion from the lectin pathways of the human complement system have recently been described (Geiss-Liebisch et al., 2012) it still has to be elucidated how and why enterococci glycosylate their WTA. Similar to enterococci streptococci such as Streptococcus pneumoniae synthesize very complex polymers with identical repeating units in WTA and LTA, which are glycosylated with GalNAc (Denapaite et al., 2012) (Table 1 ) although recent studies on S. pneumoniae LTA suggest no any glycosylation, possibly its WTA was not glycosylated either (Gisch et al., 2013) . Additionally S. pneumoniae teichoic acids bear unusual phosphocholine residues that play crucial roles in S. pneumoniae virulence (Gehre et al., 2009; Kharat and Tomasz, 2006) . Recent studies on Lactobacillus plantarum WTA revealed strain-specific WTA types, including both GroP and RboP WTA polymers substituted with diverse ␣-d-glucosyl residues . Interestingly, L. plantarum seems to be capable of WTA-switching between WTA types with different repeating units ('alditol switching') (Bron et al., 2012; Tomita et al., 2013) . Thus, although most Gram-positive bacteria produce WTA, structure and glycosylation patterns of the polymers are highly diverse. Further investigation on the diversity of WTA and characterization of mutants with altered WTA will disclose more functions of WTA glycosylation.
Perspectives
While the S. aureus WTA biosynthesis pathway including the WTA glycosylation process is largely known now (Brown et al., 2012; Xia et al., 2010b) it remains mysterious why S. aureus glycosylates its WTA with GlcNAc in two different anomeric configurations. So far only a few functional roles of S. aureus WTA glycosylation were identified and the elucidation of staphylococcal WTA glycosylation paves the way for dissecting the protein-carbohydrate interactions in Staphylococcus-host interaction. Especially the function of ␣-O-GlcNAc-modified WTA and the significance of strain-dependent presence or absence of tarM remains unclear. Thus, the elucidation of mechanisms regulating S. aureus WTA glycosylation especially under in vivo conditions will help to understand why two different enzymatic pathways exist and how they may contribute to fitness or virulence. Moreover, exploring if and which WTA glycosyl residues are expressed in vivo will be important for vaccination approaches with WTA-specific opsonic antibodies.
During the last few years S. aureus WTA biosynthetic enzymes became promising targets for novel antibiotics because MRSA strains become highly susceptible to ␤-lactam antibiotics when lacking WTA or WTA ␤-O-GlcNAc (Brown et al., 2012; Campbell et al., 2011; Farha et al., 2013) . Crystal structures of WTA biosynthesis proteins as reported recently for S. epidermidis TagF (Lovering et al., 2010) , S. aureus TagD (Fong et al., 2006) , or B. cereus DltA (Osman et al., 2009 ) will help in the rational design of new antimicrobial drug.
It is still mysterious why the various Gram-positive bacteria are using completely different WTA biosynthesis pathways and why so many different WTA structures exist. Amazingly a common feature of various phages infecting distantly related Gram-positive bacteria
